<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01593982</url>
  </required_header>
  <id_info>
    <org_study_id>0181/08</org_study_id>
    <nct_id>NCT01593982</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts</brief_title>
  <acronym>rTMSinADHD</acronym>
  <official_title>Effect of Repetitive Transcranial Magnetic Stimulation on Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Even in the absence of a preliminary diagnosis of Attention Deficit Hyperactivity Disorder,
      symptoms of attention deficit, hyperactivity and cognitive impairment are common in cocaine
      addicts.

      Several factors indicate that repetitive transcranial magnetic stimulation might be a
      strategy to aid in the treatment of symptoms of attention deficit hyperactivity disorder and
      cognitive function in cocaine addicts.

      However, up to current days there have been no studies evaluating the effects of Repetitive
      Transcranial Magnetic Stimulation (rTMS) on neurocognitive performance of individuals
      suffering from the ADHD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial Magnetic Stimulation is a noninvasive technique that can influence specific
      areas of the brain and has very few side effects.

      The treatment with transcranial magnetic stimulation requires attendance to hospital daily
      sessions for 4 consecutive weeks. Each session lasts up to 30 minutes.

      Side effects include scalp discomfort and mild headache. No anesthesia is required.

      Stimulation aims the dorsolateral prefrontal cortex, a region previously studied to treat
      depression symptoms with positive results.

      The present technique has never been employed in previous studies, but risks are
      insignificant.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wender Utah Rating Scale (WURS) - Diagnostic Criteries ADHD (DSM IV)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Scales to assess attention deficit hyperactivity disorder symptoms will be applied at pre-treatment (T0) and post treatment - week 4 (T1).
Reduction on the scores of WURS and synptoms of ADHD diagnostic (as on the scores of Barrat Impulsiviness Scale - BIS 11 and Minnesota Cocaine Craving Scale - MCCS; and improves Hamilton Depressive Rating Scale - HDRS 17 and Hamilton Anxiety Rating Scale - HARS 14).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Battery of Neuropsychological Tests</measure>
    <time_frame>4 weeks</time_frame>
    <description>Cognitive performance battery will be applied at pre-treatment (T0) and post treatment - week 4 (T1).
Performance of neuropsychological tests - Trail Making Test; Wisconsin Card Sorting Test; Controlled Oral Word Association Test; Victoria Stroop Test; Rey Auditory Verbal Learning Test; WAIS-III (adapted for use in Brazil) subtests Cubes, Vocabulary, Digit Span; Wechsler Logical Memory and Iowa Gambling Task (IGT).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cognition Disorders</condition>
  <condition>Cocaine Dependence</condition>
  <condition>ADHD</condition>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug-free patients, receiving 20 sessions (1 session daily) of Sham (placebo) rTMS delivered to the left dorsolateral prefrontal cortex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug-free patients, receiving 20 sessions (1 session daily) of Active rTMS delivered to the left dorsolateral prefrontal cortex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>repetitive Transcranial Magnetic Stimulation (rTMS)</intervention_name>
    <description>20 daily sessions: each with 25 trains of 10 seconds at 5Hz, with a 20 second inter-train interval, at an intensity of 120% of motor threshold.
Site: Left Dorsolateral Prefrontal Cortex</description>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_label>Active rTMS</arm_group_label>
    <other_name>TMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cocaine Dependence Syndrome (alone or in combination with alcohol and/or nicotine
             dependence with symptoms of ADHD, according to the criteria of the DSM-IV-R (APA,
             2000), as well as through a structured clinical interview (SCID-1/P v 2.0)

          -  Minimum age of 18

          -  Maximum age of 40

          -  20 days or less abstinence.

          -  any psychopharmacological treatment other than clonazepam (4 mg/day)

        Exclusion Criteria:

          -  Metallic Cerebral Implant

          -  Pacemakers

          -  History of Severe Brain trauma or injury

          -  Organic Brain Disease

          -  Previous neurosurgery

          -  History of seizures

          -  Epilepsy

          -  Severe Somatic Disease

          -  History of other actual or past psychiatric diagnostics

          -  Clinically significant changes in laboratory test

          -  Any psychiatric or neurological disorder other than Cocaine Dependence with symptoms
             of ADHD

          -  Psychotic depression

          -  Suicidal propensities
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Debora Arnaut, PSYD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laboratory of Brain Stimulation - Institute of Psychiatry, General Hospital, University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Debora Arnaut, PSYD</last_name>
    <phone>551130698159</phone>
    <email>arnautdebora@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department and Institute of Psychiatry, General Hospital, University of Sao Paulo Medical School</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>SP</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debora Arnaut, PSYD</last_name>
      <phone>551126618159</phone>
      <email>arnautdebora@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Philip L Ribeiro, MD</last_name>
      <phone>551126618159</phone>
      <email>emt@hcnet.usp.br</email>
    </contact_backup>
    <investigator>
      <last_name>Debora Arnaut, PSYD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9. doi: 10.1016/j.drugalcdep.2011.12.007. Epub 2011 Dec 30.</citation>
    <PMID>22209385</PMID>
  </reference>
  <reference>
    <citation>Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry. 2012 Mar;53(3):304-12. doi: 10.1111/j.1469-7610.2011.02489.x. Epub 2011 Nov 8.</citation>
    <PMID>22066497</PMID>
  </reference>
  <reference>
    <citation>Bloch Y, Harel EV, Aviram S, Govezensky J, Ratzoni G, Levkovitz Y. Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD Subjects: a randomized controlled pilot study. World J Biol Psychiatry. 2010 Aug;11(5):755-8. doi: 10.3109/15622975.2010.484466.</citation>
    <PMID>20521875</PMID>
  </reference>
  <reference>
    <citation>Barr MS, Farzan F, Wing VC, George TP, Fitzgerald PB, Daskalakis ZJ. Repetitive transcranial magnetic stimulation and drug addiction. Int Rev Psychiatry. 2011 Oct;23(5):454-66. doi: 10.3109/09540261.2011.618827. Review.</citation>
    <PMID>22200135</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>May 22, 2012</last_update_submitted>
  <last_update_submitted_qc>May 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Repetitive Transcranial Magnetic Stimulation</keyword>
  <keyword>Cocaine Dependence</keyword>
  <keyword>Cocaine Addicts</keyword>
  <keyword>Attention Deficit Hyperactivity Disorder</keyword>
  <keyword>Cognitive Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Cocaine-Related Disorders</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

